ALBENZA (Amedra Pharmaceuticals LLC)


Welcome to the PulseAid listing for the ALBENZA drug offered from Amedra Pharmaceuticals LLC. This Antihelminthic [EPC],Cytochrome P450 1A Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Amedra Pharmaceuticals LLC
NON-PROPRIETARY NAME: albendazole
SUBSTANCE NAME: ALBENDAZOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antihelminthic [EPC],Cytochrome P450 1A Inducers [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1996-06-11
END MARKETING DATE: 0000-00-00


ALBENZA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionALBENZA from Amedra Pharmaceuticals LLC
LABELER NAME: Amedra Pharmaceuticals LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 1996-06-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52054-550_cf83e8d6-1685-4c0a-9555-d4d19ff2bf71
PRODUCT NDC: 52054-550
APPLICATION NUMBER: NDA020666

Other ALBENDAZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amedra Pharmaceuticals LLCALBENZA
Central Texas Community Health CentersALBENZA
Department of State Health Services, Pharmacy BranchALBENZA
Mckesson Rxpak IncALBENZA